SBIR-STTR Award

Rapid Tox-Based Wearable Sensing Badge for Solid Aerosol and Contact Exposure to Fentanils
Award last edited on: 9/3/2020

Sponsored Program
SBIR
Awarding Agency
DHS
Total Award Amount
$1,099,366
Award Phase
2
Solicitation Topic Code
H-SB018.1-001
Principal Investigator
Piercen Oliver

Company Information

Nano Terra Inc (AKA: Nano-terra)

737 Concord Avenue
Cambridge, MA 02138
Location: Single
Congr. District: 05
County: Middlesex

Phase I

Contract Number: 70RSAT18C00000017
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2018
Phase I Amount
$99,875
Nano Terra proposes to develop a low-cost and wearable detector badge that quickly and selec-tively alerts the user to the presence of solid fentanyl aerosols with an audible and visual alert. Current commercial fentanyl and opioid detectors are bulky and costly and have unsuitably-high limits of detection. Nano Terra will leverage their expertise in ultra-sensitive dosimetric detection of threat agents to advance their existing highly-selective opioid sensor for use in a compact wearable badge. The proposed system will be unobtrusive and inexpensive, while offering the necessary high sensitivity, high selectivity (distinguishes amongst fentanyl analogs and cutting agents), and rapid response time needed for the requirements of law enforcement and first responders. We will also develop and integrate a proof-of-concept toxicity-based sensor for opioids in which sensors are formulated to provide a real-time assessment of the effective human toxicity of operational environments containing multiple opioid species whose concentration or identity may not be known.

Phase II

Contract Number: 70RSAT19C00000009
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2019
Phase II Amount
$999,491
Clear Scientific, a wholly-owned subsidiary of Nano Terra, proposes to develop a low-cost and wearable detector badge that quickly alerts the user in real time to the presence of solid or aerosolized fentanils with an audible and visual alert. Current commercial opioid detectors are bulky, costly, and cannot be used passively in real time. Clear Scientific will leverage their expertise in ultra-sensitive dosimetric detection of threat agents to advance their highly-sensitive opioid sensor for use in a compact wearable badge. The proposed system will be unobtrusive and inexpensive, while offering the necessary high sensitivity, high selectivity (distinguishes amongst fentanyl analogs and cutting agents), and rapid response time needed for the requirements of law enforcement and first responders. The system will provide a real-time response based on the effective human toxicity of operational environments containing multiple opioid species whose concentration or identity may not be known.